Title:
【発明の名称】1-アザ三環式-4-ベンジルピペラジン
Document Type and Number:
Japanese Patent JP2003502332
Kind Code:
A
Abstract:
Disclosed are 1-Azatricyclic-4-benzylpiperazine compounds which are useful for the treatment and/or prevention of neuropsychological disorders including, but not limited to, schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders related to the use of neuroleptic agents. Pharmaceutical compositions, including packaged pharmaceutical compositions, are further provided. Compounds of the invention are also useful as probes for the localization of GABAA receptors in tissue samples.
Inventors:
Zan, Sophie
Hodgets, Kevin
Rachiwal, Stanislav
Rose water, daniel
Tarkauf, Andrew
Hodgets, Kevin
Rachiwal, Stanislav
Rose water, daniel
Tarkauf, Andrew
Application Number:
JP2001503861A
Publication Date:
January 21, 2003
Filing Date:
June 14, 2000
Export Citation:
Assignee:
Neurogen Corporation
International Classes:
A61K31/4353; A61K31/437; A61K31/496; A61K31/497; A61K31/55; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P43/00; C07D471/02; C07D471/06; C07D487/04; C07D487/06; C07D498/02; G01N33/68; G01N33/94; (IPC1-7): C07D487/06; A61K31/55; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P43/00
Attorney, Agent or Firm:
Hidekazu Miyoshi (1 outside)